Halozyme Therapeutics Inc (NASDAQ:HALO)

18.54
Delayed Data
As of Feb 16
 -0.12 / -0.64%
Today’s Change
11.41
Today|||52-Week Range
21.13
-8.49%
Year-to-Date

Today’s Trading

Previous close18.66
Today’s open18.71
Day’s range18.46 - 18.92
Volume543,645
Average volume (3 months)1,223,577
Market cap$2.6B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-224.00%
Earnings growth (this year)+139.74%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+8.61%
P/E ratioNM
Price/Sales8.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-0.66-1.71%
BPMCBlueprint Medicines ...-1.11-1.34%
XLRNAcceleron Pharma Inc-0.50-1.18%
XONIntrexon Corp-0.37-2.72%
Data as of 4:02pm ET, 02/16/2018

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)$0.72
Annual revenue (last year)$146.7M
Annual profit (last year)-$103.0M
Net profit margin-70.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts